Symbioselenkung bei homöopathisch behandelten Patienten mit komplexen Pathologien

Zusammenfassung

Nach einer Einführung in einige Schlüsselfunktionen des Mikrobioms wird die heute mögliche Diagnostik und Therapie des Mikrobioms zusammenfassend beschrieben. Anhand von 3 Kasuistiken wird die sogenannte „Symbioselenkung“ dargestellt und wie sie während oder vor der homöopathischen Behandlung komplexer Krankheitsbilder den Therapieverlauf positiv beeinflussen kann. Dabei kann gezeigt werden, dass neben Darmbeschwerden auch auf psychische Veränderungen, Allergien, autoimmune Geschehen und Hauterkrankungen positiver Einfluss genommen werden kann.

Abstract

After an introduction to some key functions of the microbiome, the diagnosis and therapy of the microbiome, which is possible today, is summarized. Based on 3 case reports, the rectification of symbiosis is presented and it is shown how it can positively influence the course of therapy during or before the homeopathic treatment of complex diseases. It is shown that in addition to bowel problems, also mental changes, allergies, autoimmune and skin diseases can be positively affected.

Schlüsselworte

Microbiome - Symbioselenkung - komplexe Pathologie - Allergie - Autoimmunerkrankung - Hauterkrankung

Keywords

Microbiome - symbiosis - complex disease - allergy - autoimmune disease - skin disease

Publication History

Article published online:
20 March 2020

• Literatur

• 1 Autenrieth IB. Die Ökologie der humanen Darmflora: Physiologische und pathophysiologische Aspekte. Journal für Ernährungsmedizin 2000; 2 (04) : 6-9
• 2 Autenrieth IB. Die Ökologie der humanen Darmflora: physiologische und pathologische Aspekte. Journal für Gastroenterologische und Hepatologische Erkrankungen 2003; 1 (01) : 14-17
• 3 Boem F, Amedei A. Healthy axis: Towards an integrated view of the gut-brain health. World Journal of Gastroenterology 2019; 25 (29) : 3838-3841
• 4 Breyner N. et al. Microbial Anti-Inflammatory Molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-κB Pathway. Frontiers in Microbiology 2017.
• 5 Bundesinstitut für Arzneimittel und Medizinprodukte. Im Internet:. www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RV_STP/s-z/symbioflor2.html; Stand: 21.01.2020
• 6 Consortium, Integrative HMP (iHMP) Research Network. The Integrative Human Microbiome Project. Nature 2019; 569 (7758): 641-648
• 7 Corrêa-Oliveira R. et al. Regulation of immune cell function by short-chain fatty acids. Clinical and Translational Immunology 2016; 5 (04) : e73
• 8 Enck P. et al. A mixture of Escherichia Coli (DSM 17252) and Enterococcus Faecalis (DSM 16440) for treatment of the Irritable Bowel Syndrome: A randomized controlled trial with primary care physicians. Neurogastroenterol Motil 2008; 20 (10) : 1103-1109
• 9 Enck P. et al. Randomized controlled treatment trial of Irritable Bowel Syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo. Z Gastroenterol 2009; 47 (02) : 209-214
• 10 Fasano A. Intestinal permeability and its eegulation by Zonulin: Diagnostic and therapeutic implications. Clin Gastroenterol Hepatology 2012; 10 (10) : 1096-1100
• 11 Gill SR. et al. Metagenmic analysis of the human distal gut microbiome. Science 2011; 312 (5778): 1355-1359
• 12 Goeser F. Mikrobiomforschung: Wie körpereigene Keime als „Superorgan“ agieren. Deutsches Ärzteblatt 2012; 109: A1317-A1318
• 13 Hahne D. Mikrobiom und intestinale Gesundheit: Eine hohe Diversität von Darmbakterien ist günstig. Deutsche Ärzteblatt 2017; 114 (05) : A222-A223
• 14 Hahnemann SCF. Organon der Heilkunst. Berg am Starnberger See: O.-Verlag; 1985: 63
• 15 Halmos EP, Mack A, Gibson PR. Review article: Emulsifiers in the food supply and implications for gastrointestinal disease. Aliment Pharmacol Ther 2018; 49 (01) : 41-50
• 16 Holder MK. et al. Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner. International Journal of Scientific Reports 2019; 9: 172
• 17 Holota Y. et al. The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity. PloS One 2019; 14 (08) : e020642
• 18 Integrative HMP (iHMP) Research Network Consortium. Dynamic analysis of microbiome-host omics profiles during periods of human health and disease. Cell Host Microbe 2014; 16 (03) : 276-289
• 19 Johansson ME, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nature reviews Immunology 2016; 16 (10) : 639-649
• 20 Lamb CA, Kennedy NA, Raine T. Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019; 68 (Suppl3): s1-s106
• 21 Lau S. et al. Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with parent an a randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology 2012; 129 (04) : 1040-1047
• 22 LeBlanc JG. et al. Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Current Opinion in Biotechnology 2013; 24 (02) : 160-168
• 23 Ledochowski M. et al. Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scandinavian Journal of Gastroenterology 2000; 35: 1048-1052
• 24 Mafarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. The Proceedings of the Nutrition Society 2003; 62: 67-72
• 25 McCormick BJJ. et al. Intestinal permeability and inflammation mediate the association between nutrient density of complementary foods and biochemical measures of micronutrient status in young children: Results from the MAL-ED Study. American Journal of Clinical Nutrition 2019; 110: 1015-1025
• 26 Nobel YR. et al. Metabolic and metagenomic outcomes from early-life. Nat Commun 2015 6. 7486
• 27 Palleja A, Mikkelsen K, Forslund S. et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature microbiology 2018; 3: 1255-1265
• 28 Quevrain E. et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease. Gut 2016; 65: 415-425
• 29 Riedel C, Foata F. et al. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World Journal of Gastroenterology 2006; 12: 3729-3735
• 30 Schütz B, Hofmann H, Deutschbein R. Die intestinale Mikrobiota in der Onkologie. Deutsche Zeitschrift für Onkologie; Komplementäre und integrative Ansätze für die Praxis 2019: 108-112
• 31 Sicard JF, Le Bihan G, Vogeleer P. Interactions of intestinal bacteria with components of the intestinal mucus. Frontiers in Cellular and Infection Microbiology. 2017 .
• 32 Sivaprakasam S. et al. Short-chain fatty acid transporters: Role in colonic homeostasis. Comprehensive Physiology 2017; 8: 299-314
• 33 Strygler B. et al. Alpha 1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterology 1990; 99: 1380-1387
• 34 Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 2016; 4 (04) : e1251384
• 35 The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214
• 36 US National Library, of Med. Nat. Inst. of Health. Pubmed.gov. Im Internet:. https://pubmed.ncbi.nlm.nih.gov/?term=intestinal+microbiome ; Stand: 21.01.2020
• 37 Varea V, de Carpi JM. et al. Malabsorption of carbohydrates and depression in children and adolescents. Journal of Pediatric Gastroenterology and Nutrition 2005; 40: 561-565
• 38 Ventura M, Le Blanc JG, Milani C. et al. Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Current Opinion in Biotechnology 2013: 160-168
• 39 Wrzosek L. et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biology 2013; 61: 11
• 40 Zhou W. et al. Protective effects of bifidobacteria on intestines in newborn rats with necrotizing enterocolitis and its regulation on TLR2 and TLR4. Genetics and molecular research 2015 14. 11505-11514